PMID,Title,Journal,Year
36250175,Influence of comorbidities on treatment considerations for first-line biologic prescribing in patients with inflammatory bowel disease in the UK.,Frontline gastroenterology,2022
31646853,Therapeutic drug monitoring with vedolizumab in inflammatory bowel disease.,Minerva gastroenterologica e dietologica,2019
30931477,Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab.,Inflammatory bowel diseases,2019
